Analysed BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) News Sources
Wedbush Bullish on Black Diamond Therapeutics (BDTX) Following Progress in Silevertinib Program
25-03-2026
yahoo.com
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
16-03-2026
yahoo.com
Black Diamond Therapeutics Teases Next-Quarter PFS Data for Silevertinib at TD Cowen Conference
06-03-2026
marketbeat.com
What is the current price of BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ)?
The current price of BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) is $2.61.
BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) since the previous trading day is $0.05.
BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) since the previous trading day is 1.9531%.
What is the most recent average sentiment score for BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ)?
The most recent average sentiment score for BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ)?
The most recent sentiment for BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ) is .
SEC-8K** Filing Available For BLACK DIAMOND THERAPEUTICS I (BDTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.